China · Delayed Price · Currency is CNY Nanjing Vazyme Biotech Statistics
Total Valuation
SHA:688105 has a market cap or net worth of CNY 9.01 billion. The enterprise value is 7.07 billion.
| Market Cap | 9.01B |
| Enterprise Value | 7.07B |
Important Dates
The next confirmed earnings date is Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
SHA:688105 has 516.99 million shares outstanding. The number of shares has increased by 28.92% in one year.
| Current Share Class | 516.99M |
| Shares Outstanding | 516.99M |
| Shares Change (YoY) | +28.92% |
| Shares Change (QoQ) | -37.50% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 11.48% |
| Float | 175.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 84.40 |
| PS Ratio | 6.37 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 53.65 |
| P/OCF Ratio | 42.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 225.31, with an EV/FCF ratio of 42.10.
| EV / Earnings | n/a |
| EV / Sales | 5.00 |
| EV / EBITDA | 225.31 |
| EV / EBIT | n/a |
| EV / FCF | 42.10 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.27.
| Current Ratio | 3.39 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 32.12 |
| Debt / FCF | 6.00 |
| Interest Coverage | -4.23 |
Financial Efficiency
Return on equity (ROE) is -0.58% and return on invested capital (ROIC) is -5.43%.
| Return on Equity (ROE) | -0.58% |
| Return on Assets (ROA) | -1.19% |
| Return on Invested Capital (ROIC) | -5.43% |
| Return on Capital Employed (ROCE) | -2.49% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | 470,869 |
| Profits Per Employee | -4,777 |
| Employee Count | 3,002 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | -15.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.81% in the last 52 weeks. The beta is 0.65, so SHA:688105's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -10.81% |
| 50-Day Moving Average | 16.22 |
| 200-Day Moving Average | 16.22 |
| Relative Strength Index (RSI) | 51.33 |
| Average Volume (20 Days) | 9,052,693 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688105 had revenue of CNY 1.41 billion and -14.34 million in losses. Loss per share was -0.03.
| Revenue | 1.41B |
| Gross Profit | 950.20M |
| Operating Income | -98.80M |
| Pretax Income | -37.44M |
| Net Income | -14.34M |
| EBITDA | -11.39M |
| EBIT | -98.80M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 2.94 billion in cash and 1.01 billion in debt, with a net cash position of 1.93 billion or 3.74 per share.
| Cash & Cash Equivalents | 2.94B |
| Total Debt | 1.01B |
| Net Cash | 1.93B |
| Net Cash Per Share | 3.74 |
| Equity (Book Value) | 3.79B |
| Book Value Per Share | 7.35 |
| Working Capital | 2.69B |
Cash Flow
In the last 12 months, operating cash flow was 209.68 million and capital expenditures -41.82 million, giving a free cash flow of 167.86 million.
| Operating Cash Flow | 209.68M |
| Capital Expenditures | -41.82M |
| Depreciation & Amortization | 87.40M |
| Net Borrowing | -236.16M |
| Free Cash Flow | 167.86M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 67.22%, with operating and profit margins of -6.99% and -1.01%.
| Gross Margin | 67.22% |
| Operating Margin | -6.99% |
| Pretax Margin | -2.65% |
| Profit Margin | -1.01% |
| EBITDA Margin | -0.81% |
| EBIT Margin | -6.99% |
| FCF Margin | 11.87% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 2.21%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 2.21% |
| Dividend Growth (YoY) | 261.12% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -28.92% |
| Shareholder Yield | -26.66% |
| Earnings Yield | -0.16% |
| FCF Yield | 1.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SHA:688105 is 18.80, which is 7.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 18.80 |
| Price Target Difference | 7.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 18.35% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 3, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:688105 has an Altman Z-Score of 5.23 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.23 |
| Piotroski F-Score | 4 |